CompletedPhase 2/3

Women-Focused HIV Prevention in the Western Cape

South Africa720 participantsStarted 2008-09-26

Plain-language summary

The purpose of this study is to test the effectiveness of a woman-focused HIV prevention intervention combined with voluntary counseling and testing (VCT), compared to VCT only, and VCT combined with an attention-control nutrition intervention.

Who can participate

Age range18 Years – 33 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * To be eligible for the study, participants must be: (a) female; (b) report use of at least two drugs-alcohol, marijuana, methamphetamine (tik), Mandrax (methaqualone), cocaine (crack and/or powder), heroin (Thai White), glue, MDMA (ecstasy), or LSD-at least once a week in the past 90 days; (c) be sexually active within the past 30 days with a male partner; (d) be aged 18 to 33 years; (e) live in the communities around the airport; and (f) provide verbal consent to be screened for eligibility and written consent to participate in the study. Exclusion Criteria: * If participants do not meet all of the inclusion criteria, they will be excluded from the study.

What they're measuring

Reduction in substance abuse, sexual risk behaviors and victimization.

Timeframe: Baseline, 3-month, 6-month, 9-month and 12-month

Trial details

NCT IDNCT00729391

SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sponsor typeNIH

Study typeINTERVENTIONAL

Primary completion2012-01

View on ClinicalTrials.gov More HIV trials